Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2024-04-29 AGM Information
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a formal notice announcing the Annual General Meeting (AGM) of Namyue Holdings Limited. It includes details such as the date, time, venue, agenda items including receiving audited financial statements, re-election of directors, re-appointment of auditors, and approval of share issuance mandates. The document does not contain the actual financial statements or detailed reports but serves as an invitation and agenda for the AGM. The presence of phrases like 'NOTICE OF ANNUAL GENERAL MEETING' and detailed meeting logistics confirms this is an AGM notice. Therefore, the document fits the category of AGM Information (AGM-R). The document length (7965 characters) is consistent with a detailed notice but not a full report. Hence, the classification is AGM-R with high confidence.
2024-04-29 English
Form of proxy for the Annual General Meeting to be held on Friday, 14 June 2024 at 10:30 a.m.
AGM Information Classification · 95% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Namyue Holdings Limited, scheduled for 14 June 2024. It includes instructions for shareholders to appoint proxies to vote on resolutions such as receiving the audited financial statements, re-electing directors, appointing auditors, and granting mandates. The content is procedural and related to the conduct of the AGM rather than the AGM materials or presentations themselves. This type of document is typically classified as AGM Information (AGM-R) because it is a material shared for the AGM to facilitate shareholder participation and voting.
2024-04-29 English
GENERAL MANDATE FOR THE ISSUE OF SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from Namyue Holdings Limited dated 30 April 2024, containing detailed information about the upcoming Annual General Meeting (AGM) scheduled for 14 June 2024. It includes a notice of the AGM, details on the general mandate for the issue of shares, re-election of directors, and proxy instructions. The document also contains appendices with the notice of the AGM and details of directors to be re-elected. The content is typical of materials sent to shareholders in advance of an AGM to inform them of the meeting agenda and resolutions to be voted on. It is not the AGM minutes or results, nor is it a full annual report or financial statement. The document is a circular containing the AGM notice and related information, which fits the category of AGM Information (AGM-R).
2024-04-29 English
2023 Annual Report
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2023' and contains detailed sections typical of an annual report, including Corporate Information, Chairman's Statement, Management Discussion and Analysis, Directors' Report, Corporate Governance Report, Independent Auditor's Report, and Audited Financial Statements. It covers the full fiscal year ended 31 December 2023 and includes comprehensive financial data and analysis. The length of the document (15,000 characters) and the presence of extensive financial statements and management commentary confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-29 English
UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2024
Interim / Quarterly Report Classification · 95% confidence The document is an announcement by Namyue Holdings Limited presenting unaudited financial information for the three months ended 31 March 2024. It includes financial highlights, performance analysis, and prospects. The document explicitly states that the financial information is unaudited and is for a quarterly period, indicating it is an interim or quarterly financial report. The length of the document (8130 characters) and the presence of substantive financial data and analysis confirm it is a full interim report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-26 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Namyue Holdings Limited regarding the date of a board meeting to consider and approve the unaudited financial information for the quarter ended 31 March 2024. It does not contain the financial information itself but only announces the upcoming board meeting and the intention to release the quarterly financial results. The document length is short (1347 characters), and it explicitly states the purpose is to consider and approve the announcement of unaudited financial information, indicating this is a notice rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2024-04-16 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.